,pmid,rpsid,pmidlink,components_type,rna_id,rna_id_interface,rnas,rna_length,rna_sequence,rna_classification,source,protein_sequence,protein_name,protein_region,protein_modification,protein_sequence_length,Uniprot ID,mark,link,IDR,low complexity domain,In_vitrovivo,solute_concentration,salt_concentration,buffer,temperature,incubation_time,other_requirement,detection_method,morphology,description,rna_length_num
0,PMID: 22398450,RNAPS0000051,https://pubmed.ncbi.nlm.nih.gov/22398450,RNA + protein,-,-,(UCUCUAAAAA)5,50nt,UCUCUAAAAAUCUCUAAAAAUCUCUAAAAAUCUCUAAAAAUCUCUAAAAA,repeat RNA,-,"sp|P26599|PTBP1_HUMAN Polypyrimidine tract-binding protein 1 OS=Homo sapiens OX=9606 GN=PTBP1 PE=1 SV=1|length=531aa|residues=1-531
MDGIVPDIAVGTKRGSDELFSTCVTNGPFIMSSNSASAANGNDSKKFKGDSRSAGVPSRV
IHIRKLPIDVTEGEVISLGLPFGKVTNLLMLKGKNQAFIEMNTEEAANTMVNYYTSVTPV
LRGQPIYIQFSNHKELKTDSSPNQARAQAALQAVNSVQSGNLALAASAAAVDAGMAMAGQ
SPVLRIIVENLFYPVTLDVLHQIFSKFGTVLKIITFTKNNQFQALLQYADPVSAQHAKLS
LDGQNIYNACCTLRIDFSKLTSLNVKYNNDKSRDYTRPDLPSGDSQPSLDQTMAAAFGLS
VPNVHGALAPLAIPSAAAAAAAAGRIAIPGLAGAGNSVLLVSNLNPERVTPQSLFILFGV
YGDVQRVKILFNKKENALVQMADGNQAQLAMSHLNGHKLHGKPIRITLSKHQNVQLPREG
QEDQGLTKDYGNSPLHRFKKPGSKNFQNIFPPSATLHLSNIPPSVSEEDLKVLFSSNGGV
VKGFKFFQKDRKMALIQMGSVEEAVQALIDLHNHDLGENHHLRVSFSKSTI",PTBP1,-,-,531aa(1-531),P26599,"DrLLPS,LLPSDB,PhaSepDB","http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-0970,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0010,http://db.phasep.pro/browse/",-,"[32-44],[162-179],[306-335]",In vitro,136 µM [PTBP1];|80 µM RNA,"170 mM NaCl, 30 mM KCl, 1 mM MgCl2","170 mM NaCl, 30 mM KCl, 1 mM MgCl2",RT,"imme diately,> 2day s",other_molecular:1 mM ATP,Differential interference contrast microscopy,liquid,"Analogous droplets were also observed for an unrelated SH35-ligand5 pair and for the tetravalent RNA binding protein PTB interacting with an RNA oligonucleotide. Thus, liquid-liquiddemixing phase transitions may occur in many multivalent intracellular systems.",50
1,PMID: 26412307,RNAPS0000051,https://pubmed.ncbi.nlm.nih.gov/26412307,RNA + protein,-,-,(UCUCUAAAAA)5,50nt,UCUCUAAAAAUCUCUAAAAAUCUCUAAAAAUCUCUAAAAAUCUCUAAAAA,repeat RNA,-,"sp|P26599|PTBP1_HUMAN Polypyrimidine tract-binding protein 1 OS=Homo sapiens OX=9606 GN=PTBP1 PE=1 SV=1|length=531aa|residues=1-531
MDGIVPDIAVGTKRGSDELFSTCVTNGPFIMSSNSASAANGNDSKKFKGDSRSAGVPSRV
IHIRKLPIDVTEGEVISLGLPFGKVTNLLMLKGKNQAFIEMNTEEAANTMVNYYTSVTPV
LRGQPIYIQFSNHKELKTDSSPNQARAQAALQAVNSVQSGNLALAASAAAVDAGMAMAGQ
SPVLRIIVENLFYPVTLDVLHQIFSKFGTVLKIITFTKNNQFQALLQYADPVSAQHAKLS
LDGQNIYNACCTLRIDFSKLTSLNVKYNNDKSRDYTRPDLPSGDSQPSLDQTMAAAFGLS
VPNVHGALAPLAIPSAAAAAAAAGRIAIPGLAGAGNSVLLVSNLNPERVTPQSLFILFGV
YGDVQRVKILFNKKENALVQMADGNQAQLAMSHLNGHKLHGKPIRITLSKHQNVQLPREG
QEDQGLTKDYGNSPLHRFKKPGSKNFQNIFPPSATLHLSNIPPSVSEEDLKVLFSSNGGV
VKGFKFFQKDRKMALIQMGSVEEAVQALIDLHNHDLGENHHLRVSFSKSTI",PTBP1,-,-,531aa(1-531),P26599,"DrLLPS,LLPSDB,PhaSepDB","http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-0970,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0010,http://db.phasep.pro/browse/",-,"[32-44],[162-179],[306-335]",In vitro,2.5-12.5 µM [PTBP1];|0.4-2 µM RNA,100 mM NaCl,"20 mM imidazole, pH 7.0, 1 mM DTT, 10% glycerol",RT,> 12 h,-,Electron microscopy,liquid,"An important point is that, even when insufficient in themselves to promote LLPS, promiscuous IDRs can decrease the critical concentration for phase separation driven by more specific interactions. We demonstrate this phenomenon for phase separation of PTB and RNA in vitro (Figure 4) and for P-body assembly in vivo (Figure 6).",50
2,PMID: 26412307,RNAPS0000175,https://pubmed.ncbi.nlm.nih.gov/26412307,RNA + protein,-,-,(UCUCUAAAAA)5,50nt,UCUCUAAAAAUCUCUAAAAAUCUCUAAAAAUCUCUAAAAAUCUCUAAAAA,repeat RNA,-,"sp|P39936|IF4F2_YEAST Eukaryotic initiation factor 4F subunit p130 OS=Saccharomyces cerevisiae (strain ATCC 204508 / S288c) OX=559292 GN=TIF4632 PE=1 SV=1|length=85aa|residues=13-97
QQANGYKKFPPHDNQYSGANNSQPNNHYNENLYSAREPHNNKQYQSKNGKYGTNKYNNRN
NSQGNAQYYNNRFNNGYRLNNNDYN",elF4GII,IDR,-,85aa(13-97),P39936,"PhaSePro,DrLLPS,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/P39936,http://llps.biocuckoo.cn/view.php?id=LLPS-Sac-0420,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0006,http://db.phasep.pro/browse/","[14-15],[17-19],[32-44],[64-66],[86-97]",-,In vitro,30 µM [elF4GII IDR];|0.1-4 µM RNA,100 mM NaCl,"20 mM Tris pH 7.4, 1 mM DTT",RT,-,-,Electron microscopy,liquid,"A range of RNA concentrations (0.1–10 mM) did not promote phase separation of the IDR proteins up to protein concentrations of 10–30 uM, SNAP-eIF4GII IDR, which did phase separate upon addition of RNA (0.1~4 uM).",50
3,PMID: 26412307,RNAPS0000175,https://pubmed.ncbi.nlm.nih.gov/26412307,RNA + protein,-,-,(UCUCUAAAAA)5,50nt,UCUCUAAAAAUCUCUAAAAAUCUCUAAAAAUCUCUAAAAAUCUCUAAAAA,repeat RNA,-,"sp|P39936|IF4F2_YEAST Eukaryotic initiation factor 4F subunit p130 OS=Saccharomyces cerevisiae (strain ATCC 204508 / S288c) OX=559292 GN=TIF4632 PE=1 SV=1|length=85aa|residues=13-97
QQANGYKKFPPHDNQYSGANNSQPNNHYNENLYSAREPHNNKQYQSKNGKYGTNKYNNRN
NSQGNAQYYNNRFNNGYRLNNNDYN",elF4GII,IDR,-,85aa(13-97),P39936,"PhaSePro,DrLLPS,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/P39936,http://llps.biocuckoo.cn/view.php?id=LLPS-Sac-0420,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0006,http://db.phasep.pro/browse/","[14-15],[17-19],[32-44],[64-66],[86-97]",-,In vitro,30 µM [elF4GII IDR];|4-10 µM RNA,100 mM NaCl,"20 mM Tris pH 7.4, 1 mM DTT",RT,-,-,Electron microscopy,liquid,"A range of RNA concentrations (0.1–10 mM) did not promote phase separation of the IDR proteins up to protein concentrations of 10–30 uM, SNAP-eIF4GII IDR, which did phase separate upon addition of RNA (0.1~4 uM).",50
4,PMID: 26412307,RNAPS0000176,https://pubmed.ncbi.nlm.nih.gov/26412307,RNA + protein,-,-,(UCUCUAAAAA)5,50nt,UCUCUAAAAAUCUCUAAAAAUCUCUAAAAAUCUCUAAAAAUCUCUAAAAA,repeat RNA,-,"sp|P35637|FUS_HUMAN RNA-binding protein FUS OS=Homo sapiens OX=9606 GN=FUS PE=1 SV=1|length=237aa|residues=1-237
MASNDYTQQATQSYGAYPTQPGQGYSQQSSQPYGQQSYSGYSQSTDTSGYGQSSYSSYGQ
SQNTGYGTQSTPQGYGSTGGYGSSQSSQSSYGQQSSYPGYGQQPAPSSTSGSYGSSSQSS
SYGQPQSGSYSQQPSYGGQQQSYGQQQSYNPPQGYGQQNQYNSSSGGGGGGGGGGNYGQD
QSSMSSGGGSGGGYGNQDQSGGGGSGGYGQQDRGGRGRGGSGGGGGGGGGGYNRSSG",FUS,IDR,-,237aa(1-237),P35637,"PhaSePro,DrLLPS,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/P35637,http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-1390,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0002,http://db.phasep.pro/browse/",[1-237],"[17-104],[106-237]",In vitro,30 µM [FUS IDR];|0.1-10 µM RNA,100 mM NaCl,"20 mM Tris pH 7.4, 1 mM DTT",RT,-,-,Electron microscopy,solid,"A range of RNA concentrations (0.1–10 mM) did not promote phase separation of the IDR proteins up to protein concentrations of 10–30 uM, SNAP-eIF4GII IDR, which did phase separate upon addition of RNA (0.1~4 uM).",50
5,PMID: 26412307,RNAPS0000177,https://pubmed.ncbi.nlm.nih.gov/26412307,RNA + protein,-,-,(UCUCUAAAAA)5,50nt,UCUCUAAAAAUCUCUAAAAAUCUCUAAAAAUCUCUAAAAAUCUCUAAAAA,repeat RNA,-,"sp|P09651-2|ROA1_HUMAN Isoform A1-A of Heterogeneous nuclear ribonucleoprotein A1 OS=Homo sapiens OX=9606 GN=HNRNPA1|length=135aa|residues=186-320
MASASSSQRGRSGSGNFGGGRGGGFGGNDNFGRGGNFSGRGGFGGSRGGGGYGGSGDGYN
GFGNDGSNFGGGGSYNDFGNYNNQSSNFGPMKGGNFGGRSSGPYGGGGQYFAKPRNQGGY
GGSSSSSSYGSGRRF",HNRNPA1,IDR,-,135aa(186-320),P09651,"PhaSePro,DrLLPS","https://phasepro.elte.hu/entry/P09651,http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-2438","[186-196],[197-208],[309-318]",[190-320],In vitro,10 µM [HNRNPA1 IDR];|0.1-10 µM RNA,100 mM NaCl,"20 mM Tris pH 7.4, 1 mM DTT",RT,-,-,Electron microscopy,liquid,"A range of RNA concentrations (0.1–10 mM) did not promote phase separation of the IDR proteins up to protein concentrations of 10–30 uM, SNAP-eIF4GII IDR, which did phase separate upon addition of RNA (0.1~4 uM).",50
6,PMID: 26412307,RNAPS0000179,https://pubmed.ncbi.nlm.nih.gov/26412307,RNA + protein,-,-,(UCUCUAAAAA)5,50nt,UCUCUAAAAAUCUCUAAAAAUCUCUAAAAAUCUCUAAAAAUCUCUAAAAA,repeat RNA,-,"sp|P40070|LSM4_YEAST U6 snRNA-associated Sm-like protein LSm4 OS=Saccharomyces cerevisiae (strain ATCC 204508 / S288c) OX=559292 GN=LSM4 PE=1 SV=1|length=97aa|residues=91-187
QQINSNNNSNSNGPGHKRYYNNRDSNNNRGNYNRRNNNNGNSNRRPYSQNRQYNNSNSSN
INNSINSINSNNQNMNNGLGGSVQHHFNSSSPQKVEF",LSM4,IDR,-,97aa(91-187),P40070,"DrLLPS,LLPSDB,PhaSepDB","http://llps.biocuckoo.cn/view.php?id=LLPS-Sac-0080,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0005,http://db.phasep.pro/browse/",-,"[94-102],[108-135],[138-167]",In vitro,30 µM [Lsm4 IDR];|0.1-10 µM RNA,100 mM NaCl,"20 mM Tris pH 7.4, 1 mM DTT",RT,-,-,Electron microscopy,solid,"A range of RNA concentrations (0.1–10 mM) did not promote phase separation of the IDR proteins up to protein concentrations of 10–30 uM, SNAP-eIF4GII IDR, which did phase separate upon addition of RNA (0.1~4 uM).",50
7,PMID: 26412307,RNAPS0000367,https://pubmed.ncbi.nlm.nih.gov/26412307,RNA + protein,-,-,(UCUCUAAAAA)5,50nt,UCUCUAAAAAUCUCUAAAAAUCUCUAAAAAUCUCUAAAAAUCUCUAAAAA,repeat RNA,-,"A fusion protein construct [PTB]-[elF4GII IDR] with PTB residues 1-531 fused to elF4GII residues 13-97|Linker is missing|length=616aa|residues=1-531/13-97
MDGIVPDIAVGTKRGSDELFSTCVTNGPFIMSSNSASAANGNDSKKFKGDSRSAGVPSRV
IHIRKLPIDVTEGEVISLGLPFGKVTNLLMLKGKNQAFIEMNTEEAANTMVNYYTSVTPV
LRGQPIYIQFSNHKELKTDSSPNQARAQAALQAVNSVQSGNLALAASAAAVDAGMAMAGQ
SPVLRIIVENLFYPVTLDVLHQIFSKFGTVLKIITFTKNNQFQALLQYADPVSAQHAKLS
LDGQNIYNACCTLRIDFSKLTSLNVKYNNDKSRDYTRPDLPSGDSQPSLDQTMAAAFGLS
VPNVHGALAPLAIPSAAAAAAAAGRIAIPGLAGAGNSVLLVSNLNPERVTPQSLFILFGV
YGDVQRVKILFNKKENALVQMADGNQAQLAMSHLNGHKLHGKPIRITLSKHQNVQLPREG
QEDQGLTKDYGNSPLHRFKKPGSKNFQNIFPPSATLHLSNIPPSVSEEDLKVLFSSNGGV
VKGFKFFQKDRKMALIQMGSVEEAVQALIDLHNHDLGENHHLRVSFSKSTIQQANGYKKF
PPHDNQYSGANNSQPNNHYNENLYSAREPHNNKQYQSKNGKYGTNKYNNRNNSQGNAQYY
NNRFNNGYRLNNNDYN",PTBP1-TIF4632,IDR,-,"616aa(1-531,13-97)","P26599,P39936","PTBP1:DrLLPS,LLPSDB,PhaSepDB,
TIF4632:PhaSePro,DrLLPS,LLPSDB,PhaSepDB","http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-0970,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0010,http://db.phasep.pro/browse/;https://phasepro.elte.hu/entry/P39936,http://llps.biocuckoo.cn/view.php?id=LLPS-Sac-0420,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0006,http://db.phasep.pro/browse/","-;|[14-15],[17-19],[32-44],[64-66],[86-97]","[32-44],[162-179],[306-335];|-",In vitro,1.25 µM [PTBP1]-[TIF4632 IDR];|0.4 µM RNA,100 mM NaCl,"20 mM imidazole, pH 7.0, 1 mM DTT, 10% glycerol",RT,> 1 h;24 h,-,Electron microscopy,liquid,"All six PTB-IDR fusions phase separated upon addition of RNA, producing droplets that concentrated both molecules. At 1 hr after RNA addition, droplets formed by the eIF4GII IDR, Pub1 IDR, and Fus IDR fusions were relatively large, round, and separated into discrete structures. By contrast, the Lsm4 IDR, Tia1 IDR, and hnRNPA1 IDR fusions created droplets that were smaller, and often attached to each other in long irregular chains, as though coalescence into larger structures had been aborted.",50
8,PMID: 26412307,RNAPS0000369,https://pubmed.ncbi.nlm.nih.gov/26412307,RNA + protein,-,-,(UCUCUAAAAA)5,50nt,UCUCUAAAAAUCUCUAAAAAUCUCUAAAAAUCUCUAAAAAUCUCUAAAAA,repeat RNA,-,"A fusion protein construct [PTB]-[FUS IDR] with PTB residues 1-531 fused to FUS residues 1-237|Linker is missing|length=768aa|residues=1-531/1-237
MDGIVPDIAVGTKRGSDELFSTCVTNGPFIMSSNSASAANGNDSKKFKGDSRSAGVPSRV
IHIRKLPIDVTEGEVISLGLPFGKVTNLLMLKGKNQAFIEMNTEEAANTMVNYYTSVTPV
LRGQPIYIQFSNHKELKTDSSPNQARAQAALQAVNSVQSGNLALAASAAAVDAGMAMAGQ
SPVLRIIVENLFYPVTLDVLHQIFSKFGTVLKIITFTKNNQFQALLQYADPVSAQHAKLS
LDGQNIYNACCTLRIDFSKLTSLNVKYNNDKSRDYTRPDLPSGDSQPSLDQTMAAAFGLS
VPNVHGALAPLAIPSAAAAAAAAGRIAIPGLAGAGNSVLLVSNLNPERVTPQSLFILFGV
YGDVQRVKILFNKKENALVQMADGNQAQLAMSHLNGHKLHGKPIRITLSKHQNVQLPREG
QEDQGLTKDYGNSPLHRFKKPGSKNFQNIFPPSATLHLSNIPPSVSEEDLKVLFSSNGGV
VKGFKFFQKDRKMALIQMGSVEEAVQALIDLHNHDLGENHHLRVSFSKSTIMASNDYTQQ
ATQSYGAYPTQPGQGYSQQSSQPYGQQSYSGYSQSTDTSGYGQSSYSSYGQSQNTGYGTQ
STPQGYGSTGGYGSSQSSQSSYGQQSSYPGYGQQPAPSSTSGSYGSSSQSSSYGQPQSGS
YSQQPSYGGQQQSYGQQQSYNPPQGYGQQNQYNSSSGGGGGGGGGGNYGQDQSSMSSGGG
SGGGYGNQDQSGGGGSGGYGQQDRGGRGRGGSGGGGGGGGGGYNRSSG",PTBP1-FUS,IDR,-,"768aa(1-531,1-237)","P26599,P35637","PTBP1:DrLLPS,LLPSDB,PhaSepDB,
FUS:PhaSePro,DrLLPS,LLPSDB,PhaSepDB","http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-0970,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0010,http://db.phasep.pro/browse/;https://phasepro.elte.hu/entry/P35637,http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-1390,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0002,http://db.phasep.pro/browse/",-;|[1-237],"[32-44],[162-179],[306-335];|[17-104],[106-237]",In vitro,≥125 nM [PTBP1]-[FUS IDR];|≥20 nM RNA,100 mM NaCl,"20 mM imidazole, pH 7.0, 1 mM DTT, 10% glycerol",RT,> 12 h,-,Electron microscopy,liquid,"Adding BSA can greatly reduce the concentration threshold of proteins and RNA for phase transition.Performing the experiment in the presence of 100 mg/ml BSA to mimic protein-crowding effects within the cell allowed the detection of RNA-driven LLPS of the SNAP-PTB-FusIDR at concentrations below 10 nM (Figure 2D), which is below the cellular concentration of many of the abundant components of mRNP granules.",50
9,PMID: 26412307,RNAPS0000369,https://pubmed.ncbi.nlm.nih.gov/26412307,RNA + protein,-,-,(UCUCUAAAAA)5,50nt,UCUCUAAAAAUCUCUAAAAAUCUCUAAAAAUCUCUAAAAAUCUCUAAAAA,repeat RNA,-,"A fusion protein construct [PTB]-[FUS IDR] with PTB residues 1-531 fused to FUS residues 1-237|Linker is missing|length=768aa|residues=1-531/1-237
MDGIVPDIAVGTKRGSDELFSTCVTNGPFIMSSNSASAANGNDSKKFKGDSRSAGVPSRV
IHIRKLPIDVTEGEVISLGLPFGKVTNLLMLKGKNQAFIEMNTEEAANTMVNYYTSVTPV
LRGQPIYIQFSNHKELKTDSSPNQARAQAALQAVNSVQSGNLALAASAAAVDAGMAMAGQ
SPVLRIIVENLFYPVTLDVLHQIFSKFGTVLKIITFTKNNQFQALLQYADPVSAQHAKLS
LDGQNIYNACCTLRIDFSKLTSLNVKYNNDKSRDYTRPDLPSGDSQPSLDQTMAAAFGLS
VPNVHGALAPLAIPSAAAAAAAAGRIAIPGLAGAGNSVLLVSNLNPERVTPQSLFILFGV
YGDVQRVKILFNKKENALVQMADGNQAQLAMSHLNGHKLHGKPIRITLSKHQNVQLPREG
QEDQGLTKDYGNSPLHRFKKPGSKNFQNIFPPSATLHLSNIPPSVSEEDLKVLFSSNGGV
VKGFKFFQKDRKMALIQMGSVEEAVQALIDLHNHDLGENHHLRVSFSKSTIMASNDYTQQ
ATQSYGAYPTQPGQGYSQQSSQPYGQQSYSGYSQSTDTSGYGQSSYSSYGQSQNTGYGTQ
STPQGYGSTGGYGSSQSSQSSYGQQSSYPGYGQQPAPSSTSGSYGSSSQSSSYGQPQSGS
YSQQPSYGGQQQSYGQQQSYNPPQGYGQQNQYNSSSGGGGGGGGGGNYGQDQSSMSSGGG
SGGGYGNQDQSGGGGSGGYGQQDRGGRGRGGSGGGGGGGGGGYNRSSG",PTBP1-FUS,IDR,-,"768aa(1-531,1-237)","P26599,P35637","PTBP1:DrLLPS,LLPSDB,PhaSepDB,
FUS:PhaSePro,DrLLPS,LLPSDB,PhaSepDB","http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-0970,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0010,http://db.phasep.pro/browse/;https://phasepro.elte.hu/entry/P35637,http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-1390,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0002,http://db.phasep.pro/browse/",-;|[1-237],"[32-44],[162-179],[306-335];|[17-104],[106-237]",In vitro,≤62.5 nM [PTBP1]-[FUS IDR];|≤10 nM RNA,100 mM NaCl,"20 mM imidazole, pH 7.0, 1 mM DTT, 10% glycerol",RT,> 12 h,-,Electron microscopy,solute,"Adding BSA can greatly reduce the concentration threshold of proteins and RNA for phase transition.Performing the experiment in the presence of 100 mg/ml BSA to mimic protein-crowding effects within the cell allowed the detection of RNA-driven LLPS of the SNAP-PTB-FusIDR at concentrations below 10 nM (Figure 2D), which is below the cellular concentration of many of the abundant components of mRNP granules.",50
10,PMID: 26412307,RNAPS0000369,https://pubmed.ncbi.nlm.nih.gov/26412307,RNA + protein,-,-,(UCUCUAAAAA)5,50nt,UCUCUAAAAAUCUCUAAAAAUCUCUAAAAAUCUCUAAAAAUCUCUAAAAA,repeat RNA,-,"A fusion protein construct [PTB]-[FUS IDR] with PTB residues 1-531 fused to FUS residues 1-237|Linker is missing|length=768aa|residues=1-531/1-237
MDGIVPDIAVGTKRGSDELFSTCVTNGPFIMSSNSASAANGNDSKKFKGDSRSAGVPSRV
IHIRKLPIDVTEGEVISLGLPFGKVTNLLMLKGKNQAFIEMNTEEAANTMVNYYTSVTPV
LRGQPIYIQFSNHKELKTDSSPNQARAQAALQAVNSVQSGNLALAASAAAVDAGMAMAGQ
SPVLRIIVENLFYPVTLDVLHQIFSKFGTVLKIITFTKNNQFQALLQYADPVSAQHAKLS
LDGQNIYNACCTLRIDFSKLTSLNVKYNNDKSRDYTRPDLPSGDSQPSLDQTMAAAFGLS
VPNVHGALAPLAIPSAAAAAAAAGRIAIPGLAGAGNSVLLVSNLNPERVTPQSLFILFGV
YGDVQRVKILFNKKENALVQMADGNQAQLAMSHLNGHKLHGKPIRITLSKHQNVQLPREG
QEDQGLTKDYGNSPLHRFKKPGSKNFQNIFPPSATLHLSNIPPSVSEEDLKVLFSSNGGV
VKGFKFFQKDRKMALIQMGSVEEAVQALIDLHNHDLGENHHLRVSFSKSTIMASNDYTQQ
ATQSYGAYPTQPGQGYSQQSSQPYGQQSYSGYSQSTDTSGYGQSSYSSYGQSQNTGYGTQ
STPQGYGSTGGYGSSQSSQSSYGQQSSYPGYGQQPAPSSTSGSYGSSSQSSSYGQPQSGS
YSQQPSYGGQQQSYGQQQSYNPPQGYGQQNQYNSSSGGGGGGGGGGNYGQDQSSMSSGGG
SGGGYGNQDQSGGGGSGGYGQQDRGGRGRGGSGGGGGGGGGGYNRSSG",PTBP1-FUS,IDR,-,"768aa(1-531,1-237)","P26599,P35637","PTBP1:DrLLPS,LLPSDB,PhaSepDB,
FUS:PhaSePro,DrLLPS,LLPSDB,PhaSepDB","http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-0970,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0010,http://db.phasep.pro/browse/;https://phasepro.elte.hu/entry/P35637,http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-1390,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0002,http://db.phasep.pro/browse/",-;|[1-237],"[32-44],[162-179],[306-335];|[17-104],[106-237]",In vitro,1-250 nM [PTBP1]-[FUS IDR];|1-40 nM RNA,100 mM NaCl,"20 mM imidazole, pH 7.0, 1 mM DTT, 10% glycerol",RT,> 12 h,other_molecular:100 mg/ml BSA,Electron microscopy,liquid,"Adding BSA can greatly reduce the concentration threshold of proteins and RNA for phase transition.Performing the experiment in the presence of 100 mg/ml BSA to mimic protein-crowding effects within the cell allowed the detection of RNA-driven LLPS of the SNAP-PTB-FusIDR at concentrations below 10 nM (Figure 2D), which is below the cellular concentration of many of the abundant components of mRNP granules.",50
11,PMID: 26412307,RNAPS0000369,https://pubmed.ncbi.nlm.nih.gov/26412307,RNA + protein,-,-,(UCUCUAAAAA)5,50nt,UCUCUAAAAAUCUCUAAAAAUCUCUAAAAAUCUCUAAAAAUCUCUAAAAA,repeat RNA,-,"A fusion protein construct [PTB]-[FUS IDR] with PTB residues 1-531 fused to FUS residues 1-237|Linker is missing|length=768aa|residues=1-531/1-237
MDGIVPDIAVGTKRGSDELFSTCVTNGPFIMSSNSASAANGNDSKKFKGDSRSAGVPSRV
IHIRKLPIDVTEGEVISLGLPFGKVTNLLMLKGKNQAFIEMNTEEAANTMVNYYTSVTPV
LRGQPIYIQFSNHKELKTDSSPNQARAQAALQAVNSVQSGNLALAASAAAVDAGMAMAGQ
SPVLRIIVENLFYPVTLDVLHQIFSKFGTVLKIITFTKNNQFQALLQYADPVSAQHAKLS
LDGQNIYNACCTLRIDFSKLTSLNVKYNNDKSRDYTRPDLPSGDSQPSLDQTMAAAFGLS
VPNVHGALAPLAIPSAAAAAAAAGRIAIPGLAGAGNSVLLVSNLNPERVTPQSLFILFGV
YGDVQRVKILFNKKENALVQMADGNQAQLAMSHLNGHKLHGKPIRITLSKHQNVQLPREG
QEDQGLTKDYGNSPLHRFKKPGSKNFQNIFPPSATLHLSNIPPSVSEEDLKVLFSSNGGV
VKGFKFFQKDRKMALIQMGSVEEAVQALIDLHNHDLGENHHLRVSFSKSTIMASNDYTQQ
ATQSYGAYPTQPGQGYSQQSSQPYGQQSYSGYSQSTDTSGYGQSSYSSYGQSQNTGYGTQ
STPQGYGSTGGYGSSQSSQSSYGQQSSYPGYGQQPAPSSTSGSYGSSSQSSSYGQPQSGS
YSQQPSYGGQQQSYGQQQSYNPPQGYGQQNQYNSSSGGGGGGGGGGNYGQDQSSMSSGGG
SGGGYGNQDQSGGGGSGGYGQQDRGGRGRGGSGGGGGGGGGGYNRSSG",PTBP1-FUS,IDR,-,"768aa(1-531,1-237)","P26599,P35637","PTBP1:DrLLPS,LLPSDB,PhaSepDB,
FUS:PhaSePro,DrLLPS,LLPSDB,PhaSepDB","http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-0970,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0010,http://db.phasep.pro/browse/;https://phasepro.elte.hu/entry/P35637,http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-1390,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0002,http://db.phasep.pro/browse/",-;|[1-237],"[32-44],[162-179],[306-335];|[17-104],[106-237]",In vitro,3 µM [PTBP1]-[FUS IDR];|0.5 µM RNA,100 mM NaCl,"20 mM imidazole, pH 7.0, 1 mM DTT, 10% glycerol",RT,-,-,Electron microscopy,liquid,"At 100 mM NaCl and protein concentrations of 1.25–2.5 mM, all six SNAP-PTB-IDR fusions phase separated upon addition of 0.4–0.8 mM RNA, producing droplets that concentrated both molecules (Figures 2 and S2A, showing RNA enrichment).",50
12,PMID: 26412307,RNAPS0000369,https://pubmed.ncbi.nlm.nih.gov/26412307,RNA + protein,-,-,(UCUCUAAAAA)5,50nt,UCUCUAAAAAUCUCUAAAAAUCUCUAAAAAUCUCUAAAAAUCUCUAAAAA,repeat RNA,-,"A fusion protein construct [PTB]-[FUS IDR] with PTB residues 1-531 fused to FUS residues 1-237|Linker is missing|length=768aa|residues=1-531/1-237
MDGIVPDIAVGTKRGSDELFSTCVTNGPFIMSSNSASAANGNDSKKFKGDSRSAGVPSRV
IHIRKLPIDVTEGEVISLGLPFGKVTNLLMLKGKNQAFIEMNTEEAANTMVNYYTSVTPV
LRGQPIYIQFSNHKELKTDSSPNQARAQAALQAVNSVQSGNLALAASAAAVDAGMAMAGQ
SPVLRIIVENLFYPVTLDVLHQIFSKFGTVLKIITFTKNNQFQALLQYADPVSAQHAKLS
LDGQNIYNACCTLRIDFSKLTSLNVKYNNDKSRDYTRPDLPSGDSQPSLDQTMAAAFGLS
VPNVHGALAPLAIPSAAAAAAAAGRIAIPGLAGAGNSVLLVSNLNPERVTPQSLFILFGV
YGDVQRVKILFNKKENALVQMADGNQAQLAMSHLNGHKLHGKPIRITLSKHQNVQLPREG
QEDQGLTKDYGNSPLHRFKKPGSKNFQNIFPPSATLHLSNIPPSVSEEDLKVLFSSNGGV
VKGFKFFQKDRKMALIQMGSVEEAVQALIDLHNHDLGENHHLRVSFSKSTIMASNDYTQQ
ATQSYGAYPTQPGQGYSQQSSQPYGQQSYSGYSQSTDTSGYGQSSYSSYGQSQNTGYGTQ
STPQGYGSTGGYGSSQSSQSSYGQQSSYPGYGQQPAPSSTSGSYGSSSQSSSYGQPQSGS
YSQQPSYGGQQQSYGQQQSYNPPQGYGQQNQYNSSSGGGGGGGGGGNYGQDQSSMSSGGG
SGGGYGNQDQSGGGGSGGYGQQDRGGRGRGGSGGGGGGGGGGYNRSSG",PTBP1-FUS,IDR,-,"768aa(1-531,1-237)","P26599,P35637","PTBP1:DrLLPS,LLPSDB,PhaSepDB,
FUS:PhaSePro,DrLLPS,LLPSDB,PhaSepDB","http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-0970,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0010,http://db.phasep.pro/browse/;https://phasepro.elte.hu/entry/P35637,http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-1390,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0002,http://db.phasep.pro/browse/",-;|[1-237],"[32-44],[162-179],[306-335];|[17-104],[106-237]",In vitro,0.5-12.5 µM [PTBP1]-[FUS IDR];|0.1-2 µM RNA,100 mM NaCl,"20 mM imidazole, pH 7.0, 1 mM DTT, 10% glycerol",RT,> 12 h,-,Electron microscopy,"solute, liquid","At 100 mM NaCl and protein concentrations of 1.25–2.5 mM, all six SNAP-PTB-IDR fusions phase separated upon addition of 0.4–0.8 mM RNA, producing droplets that concentrated both molecules (Figures 2 and S2A, showing RNA enrichment).",50
13,PMID: 26412307,RNAPS0000369,https://pubmed.ncbi.nlm.nih.gov/26412307,RNA + protein,-,-,(UCUCUAAAAA)5,50nt,UCUCUAAAAAUCUCUAAAAAUCUCUAAAAAUCUCUAAAAAUCUCUAAAAA,repeat RNA,-,"A fusion protein construct [PTB]-[FUS IDR] with PTB residues 1-531 fused to FUS residues 1-237|Linker is missing|length=768aa|residues=1-531/1-237
MDGIVPDIAVGTKRGSDELFSTCVTNGPFIMSSNSASAANGNDSKKFKGDSRSAGVPSRV
IHIRKLPIDVTEGEVISLGLPFGKVTNLLMLKGKNQAFIEMNTEEAANTMVNYYTSVTPV
LRGQPIYIQFSNHKELKTDSSPNQARAQAALQAVNSVQSGNLALAASAAAVDAGMAMAGQ
SPVLRIIVENLFYPVTLDVLHQIFSKFGTVLKIITFTKNNQFQALLQYADPVSAQHAKLS
LDGQNIYNACCTLRIDFSKLTSLNVKYNNDKSRDYTRPDLPSGDSQPSLDQTMAAAFGLS
VPNVHGALAPLAIPSAAAAAAAAGRIAIPGLAGAGNSVLLVSNLNPERVTPQSLFILFGV
YGDVQRVKILFNKKENALVQMADGNQAQLAMSHLNGHKLHGKPIRITLSKHQNVQLPREG
QEDQGLTKDYGNSPLHRFKKPGSKNFQNIFPPSATLHLSNIPPSVSEEDLKVLFSSNGGV
VKGFKFFQKDRKMALIQMGSVEEAVQALIDLHNHDLGENHHLRVSFSKSTIMASNDYTQQ
ATQSYGAYPTQPGQGYSQQSSQPYGQQSYSGYSQSTDTSGYGQSSYSSYGQSQNTGYGTQ
STPQGYGSTGGYGSSQSSQSSYGQQSSYPGYGQQPAPSSTSGSYGSSSQSSSYGQPQSGS
YSQQPSYGGQQQSYGQQQSYNPPQGYGQQNQYNSSSGGGGGGGGGGNYGQDQSSMSSGGG
SGGGYGNQDQSGGGGSGGYGQQDRGGRGRGGSGGGGGGGGGGYNRSSG",PTBP1-FUS,IDR,-,"768aa(1-531,1-237)","P26599,P35637","PTBP1:DrLLPS,LLPSDB,PhaSepDB,
FUS:PhaSePro,DrLLPS,LLPSDB,PhaSepDB","http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-0970,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0010,http://db.phasep.pro/browse/;https://phasepro.elte.hu/entry/P35637,http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-1390,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0002,http://db.phasep.pro/browse/",-;|[1-237],"[32-44],[162-179],[306-335];|[17-104],[106-237]",In vitro,1.25 µM [PTBP1]-[FUS IDR];|0.4 µM RNA,100 mM NaCl,"20 mM imidazole, pH 7.0, 1 mM DTT, 10% glycerol",RT,> 1 h;24 h,-,Electron microscopy,liquid,"All six PTB-IDR fusions phase separated upon addition of RNA, producing droplets that concentrated both molecules. At 1 hr after RNA addition, droplets formed by the eIF4GII IDR, Pub1 IDR, and Fus IDR fusions were relatively large, round, and separated into discrete structures. By contrast, the Lsm4 IDR, Tia1 IDR, and hnRNPA1 IDR fusions created droplets that were smaller, and often attached to each other in long irregular chains, as though coalescence into larger structures had been aborted.",50
14,PMID: 26412307,RNAPS0000048,https://pubmed.ncbi.nlm.nih.gov/26412307,RNA + protein,-,-,(UCUCUAAAAA)5,50nt,UCUCUAAAAAUCUCUAAAAAUCUCUAAAAAUCUCUAAAAAUCUCUAAAAA,repeat RNA,-,"A fusion protein construct [PTB]-[Pub1 IDR] with PTB residues 1-531 fused to Pub1 residues 243-327|Linker is missing|length=616aa|residues=1-531;243-327
MDGIVPDIAVGTKRGSDELFSTCVTNGPFIMSSNSASAANGNDSKKFKGDSRSAGVPSRV
IHIRKLPIDVTEGEVISLGLPFGKVTNLLMLKGKNQAFIEMNTEEAANTMVNYYTSVTPV
LRGQPIYIQFSNHKELKTDSSPNQARAQAALQAVNSVQSGNLALAASAAAVDAGMAMAGQ
SPVLRIIVENLFYPVTLDVLHQIFSKFGTVLKIITFTKNNQFQALLQYADPVSAQHAKLS
LDGQNIYNACCTLRIDFSKLTSLNVKYNNDKSRDYTRPDLPSGDSQPSLDQTMAAAFGLS
VPNVHGALAPLAIPSAAAAAAAAGRIAIPGLAGAGNSVLLVSNLNPERVTPQSLFILFGV
YGDVQRVKILFNKKENALVQMADGNQAQLAMSHLNGHKLHGKPIRITLSKHQNVQLPREG
QEDQGLTKDYGNSPLHRFKKPGSKNFQNIFPPSATLHLSNIPPSVSEEDLKVLFSSNGGV
VKGFKFFQKDRKMALIQMGSVEEAVQALIDLHNHDLGENHHLRVSFSKSTINNNNNNYQQ
RRNYGNNNRGGFRQYNSNNNNNMNMGMNMNMNMNMNNSRGMPPSSMGMPIGAMPLPSQGQ
PQQSQTIGLPPQVNPQ",PTBP1-PUB1,IDR,-,"616aa(1-531,243-327)","P26599,P32588","PTBP1:DrLLPS,LLPSDB,PhaSepDB,
FUS:PhaSePro,DrLLPS,LLPSDB,PhaSepDB","http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-0970,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0010,http://db.phasep.pro/browse/,https://phasepro.elte.hu/entry/P32588,http://llps.biocuckoo.cn/view.php?id=LLPS-Sac-0524,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0004,http://db.phasep.pro/browse/",-;|[243-262],"[32-44],[162-179],[306-335];|[243-297],[307-316]",In vitro,2.5 µM [PTBP1]-[PUB1 IDR];|0.8 µM RNA,100 mM NaCl,"20 mM imidazole, pH 7.0, 1 mM DTT, 10% glycerol",RT,> 1 h;24 h,-,Electron microscopy,liquid,"All six PTB-IDR fusions phase separated upon addition of RNA, producing droplets that concentrated both molecules. At 1 hr after RNA addition, droplets formed by the eIF4GII IDR, Pub1 IDR, and Fus IDR fusions were relatively large, round, and separated into discrete structures. By contrast, the Lsm4 IDR, Tia1 IDR, and hnRNPA1 IDR fusions created droplets that were smaller, and often attached to each other in long irregular chains, as though coalescence into larger structures had been aborted.",50
15,PMID: 26412307,RNAPS0000049,https://pubmed.ncbi.nlm.nih.gov/26412307,RNA + protein,-,-,(UCUCUAAAAA)5,50nt,UCUCUAAAAAUCUCUAAAAAUCUCUAAAAAUCUCUAAAAAUCUCUAAAAA,repeat RNA,-,"sp|P32588|PUB1_YEAST Nuclear and cytoplasmic polyadenylated RNA-binding protein PUB1 OS=Saccharomyces cerevisiae (strain ATCC 204508 / S288c) OX=559292 GN=PUB1 PE=1 SV=4|length=85aa|residues=243-327
NNNNNNYQQRRNYGNNNRGGFRQYNSNNNNNMNMGMNMNMNMNMNNSRGMPPSSMGMPIG
AMPLPSQGQPQQSQTIGLPPQVNPQ",PUB1,IDR,-,85aa(243-327),P32588,"PhaSePro,DrLLPS,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/P32588,http://llps.biocuckoo.cn/view.php?id=LLPS-Sac-0524,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0004,http://db.phasep.pro/browse/",[243-262],"[243-297],[307-316]",In vitro,30 µM [PUB1 IDR];|0.1-10 µM RNA,100 mM NaCl,"20 mM Tris pH 7.4, 1 mM DTT",RT,-,-,Fluorescence microscopy,liquid,"A range of RNA concentrations (0.1-10 mM) did not promote phase separation of the IDR proteins up to protein concentrations of 10-30 µM, SNAP-eIF4GII IDR, which did phase separate upon addition of RNA (0.1~4 µM).",50
16,PMID: 28924037,RNAPS0000051,https://pubmed.ncbi.nlm.nih.gov/28924037,RNA + protein,-,-,(UCUCUAAAAA)5,50nt,UCUCUAAAAAUCUCUAAAAAUCUCUAAAAAUCUCUAAAAAUCUCUAAAAA,repeat RNA,-,"sp|P26599|PTBP1_HUMAN Polypyrimidine tract-binding protein 1 OS=Homo sapiens OX=9606 GN=PTBP1 PE=1 SV=1|length=533aa|residues=1-531
GHMDGIVPDIAVGTKRGSDELFSTCVTNGPFIMSSNSASAANGNDSKKFKGDSRSAGVPS
RVIHIRKLPIDVTEGEVISLGLPFGKVTNLLMLKGKNQAFIEMNTEEAANTMVNYYTSVT
PVLRGQPIYIQFSNHKELKTDSSPNQARAQAALQAVNSVQSGNLALAASAAAVDAGMAMA
GQSPVLRIIVENLFYPVTLDVLHQIFSKFGTVLKIITFTKNNQFQALLQYADPVSAQHAK
LSLDGQNIYNACCTLRIDFSKLTSLNVKYNNDKSRDYTRPDLPSGDSQPSLDQTMAAAFG
LSVPNVHGALAPLAIPSAAAAAAAAGRIAIPGLAGAGNSVLLVSNLNPERVTPQSLFILF
GVYGDVQRVKILFNKKENALVQMADGNQAQLAMSHLNGHKLHGKPIRITLSKHQNVQLPR
EGQEDQGLTKDYGNSPLHRFKKPGSKNFQNIFPPSATLHLSNIPPSVSEEDLKVLFSSNG
GVVKGFKFFQKDRKMALIQMGSVEEAVQALIDLHNHDLGENHHLRVSFSKSTI",PTBP1,-,-,531aa(1-531),P26599,"DrLLPS,LLPSDB,PhaSepDB","http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-0970,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0010,http://db.phasep.pro/browse/",-,"[32-44],[162-179],[306-335]",In vitro,3.75-6.25 µM [PTBP1];|0.2-1.0 µM RNA,"150 mM KCl, 1 mM MgCl2","10 mM imidazole (pH 7.0), 1 mM EGTA, 1 mM DTT",22˚C,-,-,"Fluorescence microscopy,Turbidity measurement",liquid,"PTB undergoes LLPS when mixed with RNA and that fusion of PTB to FUS(WT) promotes this behavior. In contrast, attachment of FUS(27S) opposed LLPS of PTB + RNA. FUS(27S) is not a highly specific LLPS inhibitor but may be able to generally reduce the self-association of tethered proteins and thus oppose their LLPS.",50
17,PMID: 28924037,RNAPS0000369,https://pubmed.ncbi.nlm.nih.gov/28924037,RNA + protein,-,-,(UCUCUAAAAA)5,50nt,UCUCUAAAAAUCUCUAAAAAUCUCUAAAAAUCUCUAAAAAUCUCUAAAAA,repeat RNA,-,"A fusion protein construct [PTBP1]-[FUS IDR] with PTBP1 residues 1-531 fused to FUS residues 1-214||length=756aa|residues=1-531/1-214|mutation= FUS IDR(27S)
GHMDGIVPDIAVGTKRGSDELFSTCVTNGPFIMSSNSASAANGNDSKKFKGDSRSAGVPS
RVIHIRKLPIDVTEGEVISLGLPFGKVTNLLMLKGKNQAFIEMNTEEAANTMVNYYTSVT
PVLRGQPIYIQFSNHKELKTDSSPNQARAQAALQAVNSVQSGNLALAASAAAVDAGMAMA
GQSPVLRIIVENLFYPVTLDVLHQIFSKFGTVLKIITFTKNNQFQALLQYADPVSAQHAK
LSLDGQNIYNACCTLRIDFSKLTSLNVKYNNDKSRDYTRPDLPSGDSQPSLDQTMAAAFG
LSVPNVHGALAPLAIPSAAAAAAAAGRIAIPGLAGAGNSVLLVSNLNPERVTPQSLFILF
GVYGDVQRVKILFNKKENALVQMADGNQAQLAMSHLNGHKLHGKPIRITLSKHQNVQLPR
EGQEDQGLTKDYGNSPLHRFKKPGSKNFQNIFPPSATLHLSNIPPSVSEEDLKVLFSSNG
GVVKGFKFFQKDRKMALIQMGSVEEAVQALIDLHNHDLGENHHLRVSFSKSTIGGSAAAG
GSMASNDSTQQATQSSGASPTQPGQGSSQQSSQPSGQQSSSGSSQSTDTSGSGQSSSSSS
GQSQNTGSGTQSTPQGSGSTGGSGSSQSSQSSSGQQSSSPGSGQQPAPSSTSGSSGSSSQ
SSSSGQPQSGSSSQQPSSGGQQQSSGQQQSSNPPQGSGQQNQSNSSSGGGGGGGGGGNSG
QDQSSMSSGGGSGGGSGNQDQSGGGGSGGSGQQDRG",PTBP1-FUS,IDR,protein_mutation:FUS IDR(27S),"756aa(1-531,1-214)","P26599,P35637","PTBP1:DrLLPS,LLPSDB,PhaSepDB,
FUS:PhaSePro,DrLLPS,LLPSDB,PhaSepDB","http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-0970,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0010,http://db.phasep.pro/browse/;https://phasepro.elte.hu/entry/P35637,http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-1390,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0002,http://db.phasep.pro/browse/",-;|[1-214],"[32-44],[162-179],[306-335];|-",In vitro,3.75-6.25 µM [PTBP1]-[FUS IDR];|0-1.0 µM RNA,"150 mM KCl, 1 mM MgCl2","10 mM imidazole (pH 7.0), 1 mM EGTA, 1 mM DTT",22˚C,-,-,"Fluorescence microscopy,Turbidity measurement",solute,"PTB undergoes LLPS when mixed with RNA and that fusion of PTB to FUS(WT) promotes this behavior. In contrast, attachment of FUS(27S) opposed LLPS of PTB + RNA. FUS(27S) is not a highly specific LLPS inhibitor but may be able to generally reduce the self-association of tethered proteins and thus oppose their LLPS.",50
18,PMID: 29425497,RNAPS0000051,https://pubmed.ncbi.nlm.nih.gov/29425497,RNA + protein,-,-,(UCUCUAAAAA)5,50nt,UCUCUAAAAAUCUCUAAAAAUCUCUAAAAAUCUCUAAAAAUCUCUAAAAA,repeat RNA,-,"sp|P26599|PTBP1_HUMAN Polypyrimidine tract-binding protein 1 OS=Homo sapiens OX=9606 GN=PTBP1 PE=1 SV=1|length=531aa|residues=1-531
MDGIVPDIAVGTKRGSDELFSTCVTNGPFIMSSNSASAANGNDSKKFKGDSRSAGVPSRV
IHIRKLPIDVTEGEVISLGLPFGKVTNLLMLKGKNQAFIEMNTEEAANTMVNYYTSVTPV
LRGQPIYIQFSNHKELKTDSSPNQARAQAALQAVNSVQSGNLALAASAAAVDAGMAMAGQ
SPVLRIIVENLFYPVTLDVLHQIFSKFGTVLKIITFTKNNQFQALLQYADPVSAQHAKLS
LDGQNIYNACCTLRIDFSKLTSLNVKYNNDKSRDYTRPDLPSGDSQPSLDQTMAAAFGLS
VPNVHGALAPLAIPSAAAAAAAAGRIAIPGLAGAGNSVLLVSNLNPERVTPQSLFILFGV
YGDVQRVKILFNKKENALVQMADGNQAQLAMSHLNGHKLHGKPIRITLSKHQNVQLPREG
QEDQGLTKDYGNSPLHRFKKPGSKNFQNIFPPSATLHLSNIPPSVSEEDLKVLFSSNGGV
VKGFKFFQKDRKMALIQMGSVEEAVQALIDLHNHDLGENHHLRVSFSKSTI",PTBP1,-,-,531aa(1-531),P26599,"DrLLPS,LLPSDB,PhaSepDB","http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-0970,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0010,http://db.phasep.pro/browse/",-,"[32-44],[162-179],[306-335]",In vitro,20 µM [PTBP1];|1.6 µM RNA ,100 mM NaCl,"20 mM imidazole pH 7.0, 1 mM DTT, 10% glycerol",RT,-,other_molecular:100 mg/ml BSA,Confocal microscopy,liquid,"While SNAP-tagged PTB and RNA showed limited assembly when mixed together at concentrations of 20 mM and 1.6 mM, respectively, the addition of 100 mg/mL BSA induced robust phase separation at these concentrations. Consistent with this effect being due to molecular crowding, PTB-RNA LLPS is also stimulated by PEG or Ficoll, additional crowding agents.",50
19,PMID: 29425497,RNAPS0000051,https://pubmed.ncbi.nlm.nih.gov/29425497,RNA + protein,-,-,(UCUCUAAAAA)5,50nt,UCUCUAAAAAUCUCUAAAAAUCUCUAAAAAUCUCUAAAAAUCUCUAAAAA,repeat RNA,-,"sp|P26599|PTBP1_HUMAN Polypyrimidine tract-binding protein 1 OS=Homo sapiens OX=9606 GN=PTBP1 PE=1 SV=1|length=531aa|residues=1-531
MDGIVPDIAVGTKRGSDELFSTCVTNGPFIMSSNSASAANGNDSKKFKGDSRSAGVPSRV
IHIRKLPIDVTEGEVISLGLPFGKVTNLLMLKGKNQAFIEMNTEEAANTMVNYYTSVTPV
LRGQPIYIQFSNHKELKTDSSPNQARAQAALQAVNSVQSGNLALAASAAAVDAGMAMAGQ
SPVLRIIVENLFYPVTLDVLHQIFSKFGTVLKIITFTKNNQFQALLQYADPVSAQHAKLS
LDGQNIYNACCTLRIDFSKLTSLNVKYNNDKSRDYTRPDLPSGDSQPSLDQTMAAAFGLS
VPNVHGALAPLAIPSAAAAAAAAGRIAIPGLAGAGNSVLLVSNLNPERVTPQSLFILFGV
YGDVQRVKILFNKKENALVQMADGNQAQLAMSHLNGHKLHGKPIRITLSKHQNVQLPREG
QEDQGLTKDYGNSPLHRFKKPGSKNFQNIFPPSATLHLSNIPPSVSEEDLKVLFSSNGGV
VKGFKFFQKDRKMALIQMGSVEEAVQALIDLHNHDLGENHHLRVSFSKSTI",PTBP1,-,-,531aa(1-531),P26599,"DrLLPS,LLPSDB,PhaSepDB","http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-0970,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0010,http://db.phasep.pro/browse/",-,"[32-44],[162-179],[306-335]",In vitro,20 µM [PTBP1];|1.6 µM RNA ,100 mM NaCl,"20 mM imidazole pH 7.0, 1 mM DTT, 10% glycerol",RT,-,crowding agent:100 mg/ml Ficoll,Confocal microscopy,liquid,"While SNAP-tagged PTB and RNA showed limited assembly when mixed together at concentrations of 20 mM and 1.6 mM, respectively, the addition of 100 mg/mL BSA induced robust phase separation at these concentrations. Consistent with this effect being due to molecular crowding, PTB-RNA LLPS is also stimulated by PEG or Ficoll, additional crowding agents.",50
20,PMID: 29425497,RNAPS0000051,https://pubmed.ncbi.nlm.nih.gov/29425497,RNA + protein,-,-,(UCUCUAAAAA)5,50nt,UCUCUAAAAAUCUCUAAAAAUCUCUAAAAAUCUCUAAAAAUCUCUAAAAA,repeat RNA,-,"sp|P26599|PTBP1_HUMAN Polypyrimidine tract-binding protein 1 OS=Homo sapiens OX=9606 GN=PTBP1 PE=1 SV=1|length=531aa|residues=1-531
MDGIVPDIAVGTKRGSDELFSTCVTNGPFIMSSNSASAANGNDSKKFKGDSRSAGVPSRV
IHIRKLPIDVTEGEVISLGLPFGKVTNLLMLKGKNQAFIEMNTEEAANTMVNYYTSVTPV
LRGQPIYIQFSNHKELKTDSSPNQARAQAALQAVNSVQSGNLALAASAAAVDAGMAMAGQ
SPVLRIIVENLFYPVTLDVLHQIFSKFGTVLKIITFTKNNQFQALLQYADPVSAQHAKLS
LDGQNIYNACCTLRIDFSKLTSLNVKYNNDKSRDYTRPDLPSGDSQPSLDQTMAAAFGLS
VPNVHGALAPLAIPSAAAAAAAAGRIAIPGLAGAGNSVLLVSNLNPERVTPQSLFILFGV
YGDVQRVKILFNKKENALVQMADGNQAQLAMSHLNGHKLHGKPIRITLSKHQNVQLPREG
QEDQGLTKDYGNSPLHRFKKPGSKNFQNIFPPSATLHLSNIPPSVSEEDLKVLFSSNGGV
VKGFKFFQKDRKMALIQMGSVEEAVQALIDLHNHDLGENHHLRVSFSKSTI",PTBP1,-,-,531aa(1-531),P26599,"DrLLPS,LLPSDB,PhaSepDB","http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-0970,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0010,http://db.phasep.pro/browse/",-,"[32-44],[162-179],[306-335]",In vitro,20 µM [PTBP1];|1.6 µM RNA ,100 mM NaCl,"20 mM imidazole pH 7.0, 1 mM DTT, 10% glycerol",RT,-,crowding agent:100 mg/ml PEG,Confocal microscopy,liquid,"While SNAP-tagged PTB and RNA showed limited assembly when mixed together at concentrations of 20 mM and 1.6 mM, respectively, the addition of 100 mg/mL BSA induced robust phase separation at these concentrations. Consistent with this effect being due to molecular crowding, PTB-RNA LLPS is also stimulated by PEG or Ficoll, additional crowding agents.",50
21,PMID: 29425497,RNAPS0000051,https://pubmed.ncbi.nlm.nih.gov/29425497,RNA + protein,-,-,(UCUCUAAAAA)5,50nt,UCUCUAAAAAUCUCUAAAAAUCUCUAAAAAUCUCUAAAAAUCUCUAAAAA,repeat RNA,-,"sp|P26599|PTBP1_HUMAN Polypyrimidine tract-binding protein 1 OS=Homo sapiens OX=9606 GN=PTBP1 PE=1 SV=1|length=531aa|residues=1-531
MDGIVPDIAVGTKRGSDELFSTCVTNGPFIMSSNSASAANGNDSKKFKGDSRSAGVPSRV
IHIRKLPIDVTEGEVISLGLPFGKVTNLLMLKGKNQAFIEMNTEEAANTMVNYYTSVTPV
LRGQPIYIQFSNHKELKTDSSPNQARAQAALQAVNSVQSGNLALAASAAAVDAGMAMAGQ
SPVLRIIVENLFYPVTLDVLHQIFSKFGTVLKIITFTKNNQFQALLQYADPVSAQHAKLS
LDGQNIYNACCTLRIDFSKLTSLNVKYNNDKSRDYTRPDLPSGDSQPSLDQTMAAAFGLS
VPNVHGALAPLAIPSAAAAAAAAGRIAIPGLAGAGNSVLLVSNLNPERVTPQSLFILFGV
YGDVQRVKILFNKKENALVQMADGNQAQLAMSHLNGHKLHGKPIRITLSKHQNVQLPREG
QEDQGLTKDYGNSPLHRFKKPGSKNFQNIFPPSATLHLSNIPPSVSEEDLKVLFSSNGGV
VKGFKFFQKDRKMALIQMGSVEEAVQALIDLHNHDLGENHHLRVSFSKSTI",PTBP1,-,-,531aa(1-531),P26599,"DrLLPS,LLPSDB,PhaSepDB","http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-0970,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0010,http://db.phasep.pro/browse/",-,"[32-44],[162-179],[306-335]",In vitro,4 µM [PTBP1];|0.32 µM RNA ,100 mM NaCl,"20 mM imidazole pH 7.0, 1 mM DTT, 10% glycerol",RT,-,other_molecular:100 mg/ml BSA,Confocal microscopy,solute,"4 µM PTB and 0.32 µM RNA do not phase separate in 100 mg/mL BSA. However, we observed LLPS with identical concentrations of RNA and PTB, when PTB was fused to either the FUS or Pub1 IDRs. PTB fused to either IDR showed an increase in both the number and size of the assemblies visualized. Therefore, weak interactions of IDRs can enhance phase separation in the presence of competitor proteins, when present in molecules that also contain specific interactions which are less susceptible to competition from cellular macromolecules.",50
22,PMID: 29425497,RNAPS0000369,https://pubmed.ncbi.nlm.nih.gov/29425497,RNA + protein,-,-,(UCUCUAAAAA)5,50nt,UCUCUAAAAAUCUCUAAAAAUCUCUAAAAAUCUCUAAAAAUCUCUAAAAA,repeat RNA,-,"A fusion protein construct [PTBP1]-[FUS IDR] with PTBP1 residues 1-531 fused to FUS residues 1-237|Linker is missing|length=768aa|residues=1-531/1-237
MDGIVPDIAVGTKRGSDELFSTCVTNGPFIMSSNSASAANGNDSKKFKGDSRSAGVPSRV
IHIRKLPIDVTEGEVISLGLPFGKVTNLLMLKGKNQAFIEMNTEEAANTMVNYYTSVTPV
LRGQPIYIQFSNHKELKTDSSPNQARAQAALQAVNSVQSGNLALAASAAAVDAGMAMAGQ
SPVLRIIVENLFYPVTLDVLHQIFSKFGTVLKIITFTKNNQFQALLQYADPVSAQHAKLS
LDGQNIYNACCTLRIDFSKLTSLNVKYNNDKSRDYTRPDLPSGDSQPSLDQTMAAAFGLS
VPNVHGALAPLAIPSAAAAAAAAGRIAIPGLAGAGNSVLLVSNLNPERVTPQSLFILFGV
YGDVQRVKILFNKKENALVQMADGNQAQLAMSHLNGHKLHGKPIRITLSKHQNVQLPREG
QEDQGLTKDYGNSPLHRFKKPGSKNFQNIFPPSATLHLSNIPPSVSEEDLKVLFSSNGGV
VKGFKFFQKDRKMALIQMGSVEEAVQALIDLHNHDLGENHHLRVSFSKSTIMASNDYTQQ
ATQSYGAYPTQPGQGYSQQSSQPYGQQSYSGYSQSTDTSGYGQSSYSSYGQSQNTGYGTQ
STPQGYGSTGGYGSSQSSQSSYGQQSSYPGYGQQPAPSSTSGSYGSSSQSSSYGQPQSGS
YSQQPSYGGQQQSYGQQQSYNPPQGYGQQNQYNSSSGGGGGGGGGGNYGQDQSSMSSGGG
SGGGYGNQDQSGGGGSGGYGQQDRGGRGRGGSGGGGGGGGGGYNRSSG",PTBP1-FUS,IDR,-,"768aa(1-531,1-237)","P26599,P35637","PTBP1:DrLLPS,LLPSDB,PhaSepDB,
FUS:PhaSePro,DrLLPS,LLPSDB,PhaSepDB","http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-0970,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0010,http://db.phasep.pro/browse/;https://phasepro.elte.hu/entry/P35637,http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-1390,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0002,http://db.phasep.pro/browse/",-;|[1-237],"[32-44],[162-179],[306-335];|[17-104],[106-237]",In vitro,4 µM [PTBP1]-[FUS IDR];|0.32 µM RNA,100 mM NaCl,"20 mM imidazole pH 7.0, 1 mM DTT, 10% glycerol",RT,-,other_molecular:100 mg/ml BSA,Confocal microscopy,liquid,"4 uM PTB and 0.32 μM RNA do not phase separate in 100 mg/mL BSA. However, we observed LLPS with identical concentrations of RNA and PTB, when PTB was fused to either the FUS or Pub1 IDRs. PTB fused to either IDR showed an increase in both the number and size of the assemblies visualized. Therefore, weak interactions of IDRs can enhance phase separation in the presence of competitor proteins, when present in molecules that also contain specific interactions which are less susceptible to competition from cellular macromolecules.",50
23,PMID: 29425497,RNAPS0000048,https://pubmed.ncbi.nlm.nih.gov/29425497,RNA + protein,-,-,(UCUCUAAAAA)5,50nt,UCUCUAAAAAUCUCUAAAAAUCUCUAAAAAUCUCUAAAAAUCUCUAAAAA,repeat RNA,-,"A fusion protein construct [PTB]-[Pub1 IDR] with PTB residues 1-531 fused to Pub1 residues 243-327|Linker is missing|length=616aa|residues=1-531;243-327
MDGIVPDIAVGTKRGSDELFSTCVTNGPFIMSSNSASAANGNDSKKFKGDSRSAGVPSRV
IHIRKLPIDVTEGEVISLGLPFGKVTNLLMLKGKNQAFIEMNTEEAANTMVNYYTSVTPV
LRGQPIYIQFSNHKELKTDSSPNQARAQAALQAVNSVQSGNLALAASAAAVDAGMAMAGQ
SPVLRIIVENLFYPVTLDVLHQIFSKFGTVLKIITFTKNNQFQALLQYADPVSAQHAKLS
LDGQNIYNACCTLRIDFSKLTSLNVKYNNDKSRDYTRPDLPSGDSQPSLDQTMAAAFGLS
VPNVHGALAPLAIPSAAAAAAAAGRIAIPGLAGAGNSVLLVSNLNPERVTPQSLFILFGV
YGDVQRVKILFNKKENALVQMADGNQAQLAMSHLNGHKLHGKPIRITLSKHQNVQLPREG
QEDQGLTKDYGNSPLHRFKKPGSKNFQNIFPPSATLHLSNIPPSVSEEDLKVLFSSNGGV
VKGFKFFQKDRKMALIQMGSVEEAVQALIDLHNHDLGENHHLRVSFSKSTINNNNNNYQQ
RRNYGNNNRGGFRQYNSNNNNNMNMGMNMNMNMNMNNSRGMPPSSMGMPIGAMPLPSQGQ
PQQSQTIGLPPQVNPQ",PTBP1-PUB1,IDR,-,"616aa(1-531,243-327)","P26599,P32588","PTBP1:DrLLPS,LLPSDB,PhaSepDB,
FUS:PhaSePro,DrLLPS,LLPSDB,PhaSepDB","http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-0970,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0010,http://db.phasep.pro/browse/,https://phasepro.elte.hu/entry/P32588,http://llps.biocuckoo.cn/view.php?id=LLPS-Sac-0524,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0004,http://db.phasep.pro/browse/",-;|[243-262],"[32-44],[162-179],[306-335];|[243-297],[307-316]",In vitro,4 µM [PTBP1]-[PUB1 IDR];|0.32 µM RNA,100 mM NaCl,"20 mM imidazole pH 7.0, 1 mM DTT, 10% glycerol",RT,-,other_molecular:100 mg/ml BSA,Confocal microscopy,liquid,"4 µM PTB and 0.32 µM RNA do not phase separate in 100 mg/mL BSA. However, we observed LLPS with identical concentrations of RNA and PTB, when PTB was fused to either the FUS or Pub1 IDRs. PTB fused to either IDR showed an increase in both the number and size of the assemblies visualized. Therefore, weak interactions of IDRs can enhance phase separation in the presence of competitor proteins, when present in molecules that also contain specific interactions which are less susceptible to competition from cellular macromolecules.",50
24,PMID: 32995779,RNAPS0000438,https://pubmed.ncbi.nlm.nih.gov/32995779,RNA + protein,-,-,polyAU,-,-,repeat RNA,-,"sp|P0DTC9|NCAP_SARS2 Nucleoprotein OS=Severe acute respiratory syndrome coronavirus 2 OX=2697049 GN=N PE=1 SV=1
MSDNGPQNQRNAPRITFGGPSDSTGSNQNGERSGARSKQRRPQGLPNNTASWFTALTQHG
KEDLKFPRGQGVPINTNSSPDDQIGYYRRATRRIRGGDGKMKDLSPRWYFYYLGTGPEAG
LPYGANKDGIIWVATEGALNTPKDHIGTRNPANNAAIVLQLPQGTTLPKGFYAEGSRGGS
QASSRSSSRSRNSSRNSTPGSSRGTSPARMAGNGGDAALALLLLDRLNQLESKMSGKGQQ
QQGQTVTKKSAAEASKKPRQKRTATKAYNVTQAFGRRGPEQTQGNFGDQELIRQGTDYKH
WPQIAQFAPSASAFFGMSRIGMEVTPSGTWLTYTGAIKLDDKDPNFKDQVILLNKHIDAY
KTFPPTEPKKDKKKKADETQALPQRQKKQQTVTLLPAADLDDFSKQLQQSMSSADSTQA",SARS-CoV-2 Nucleoprotein,-,-,419aa(1-419),P0DTC9,-,-,"[1-40],[44-49],[174-174],[181-212],[233-247],[249-256],[365-391]","[175-208],[211-230],[236-249],[361-379]",In vitro,5-5000 ng/µL [polyAU];|18.5 µM [N protein],"150 mM NaCl, 5 mM MgCl2","50 mM HEPES pH 7.4, 1 mM EGTA, 1 mM DTT, 1% pluronic",RT,> 25 min,-,Microscopy,solid,"Similar to polyC RNA, polyA and polyU RNA substrates produced spherical condensates at micromolar  concentrations of the N protein (Figure 2A). However, combining N protein with polyG that forms G quadruplexes or polyAU that forms base-pair interactions led to the formation of non-spherical condensates",
25,PMID: 33523882,RNAPS0000460,https://pubmed.ncbi.nlm.nih.gov/33523882,RNA + protein,-,-,(CGG)99,297nt,CGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGG,repeat RNA,-,"sp|Q06787|FMR1_HUMAN Synaptic functional regulator FMR1 OS=Homo sapiens OX=9606 GN=FMR1 PE=1 SV=1
MEELVVEVRGSNGAFYKAFVKDVHEDSITVAFENNWQPDRQIPFHDVRFPPPVGYNKDIN
ESDEVEVYSRANEKEPCCWWLAKVRMIKGEFYVIEYAACDATYNEIVTIERLRSVNPNKP
ATKDTFHKIKLDVPEDLRQMCAKEAAHKDFKKAVGAFSVTYDPENYQLVILSINEVTSKR
AHMLIDMHFRSLRTKLSLIMRNEEASKQLESSRQLASRFHEQFIVREDLMGLAIGTHGAN
IQQARKVPGVTAIDLDEDTCTFHIYGEDQDAVKKARSFLEFAEDVIQVPRNLVGKVIGKN
GKLIQEIVDKSGVVRVRIEAENEKNVPQEEEIMPPNSLPSNNSRVGPNAPEEKKHLDIKE
NSTHFSQPNSTKVQRVLVASSVVAGESQKPELKAWQGMVPFVFVGTKDSIANATVLLDYH
LNYLKEVDQLRLERLQIDEQLRQIGASSRPPPNRTDKEKSYVTDDGQGMGRGSRPYRNRG
HGRRGPGYTSGTNSEASNASETESDHRDELSDWSLAPTEEERESFLRRGDGRRRGGGGRG
QGGRGRGGGFKGNDDHSRTDNRPRNPREAKGRTTDGSLQIRVDCNNERSVHTKTLQNTSS
EGSRLRTGKDRNQKKEKPDSVDGQQPLVNGVP",FMR1,-,-,632aa(1-632),Q06787,"PhaSePro,DrLLPS,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/Q06787,http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-2426,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0024,http://db.phasep.pro/browse/","[281-422],[443-515],[516-632]","[492-504],[527-549]",In vitro,20 ng/µl [(CGG)99];|9 µM [FMRpolyG],"25 mM NaCl, 10 mM MgCl2","10 mM tris-HCl buffer pH 7.5,12% (w/v) glycerol",23˚C,1 h,-,FRAP,liquid,We next investigated whether PpIX affects the LLPS of FMRpolyG  in vitro. The phase-separated liquid droplets and hydrogels of com plexes of fluorescein-FMRpolyG and CX rhodamine–CGG99 formed  substantially smaller droplets after PpIX treatment compared to un treated controls,297
26,PMID: 33523882,RNAPS0000460,https://pubmed.ncbi.nlm.nih.gov/33523882,RNA + protein,-,-,(CGG)99,297nt,CGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGG,repeat RNA,-,"sp|Q06787|FMR1_HUMAN Synaptic functional regulator FMR1 OS=Homo sapiens OX=9606 GN=FMR1 PE=1 SV=1
MEELVVEVRGSNGAFYKAFVKDVHEDSITVAFENNWQPDRQIPFHDVRFPPPVGYNKDIN
ESDEVEVYSRANEKEPCCWWLAKVRMIKGEFYVIEYAACDATYNEIVTIERLRSVNPNKP
ATKDTFHKIKLDVPEDLRQMCAKEAAHKDFKKAVGAFSVTYDPENYQLVILSINEVTSKR
AHMLIDMHFRSLRTKLSLIMRNEEASKQLESSRQLASRFHEQFIVREDLMGLAIGTHGAN
IQQARKVPGVTAIDLDEDTCTFHIYGEDQDAVKKARSFLEFAEDVIQVPRNLVGKVIGKN
GKLIQEIVDKSGVVRVRIEAENEKNVPQEEEIMPPNSLPSNNSRVGPNAPEEKKHLDIKE
NSTHFSQPNSTKVQRVLVASSVVAGESQKPELKAWQGMVPFVFVGTKDSIANATVLLDYH
LNYLKEVDQLRLERLQIDEQLRQIGASSRPPPNRTDKEKSYVTDDGQGMGRGSRPYRNRG
HGRRGPGYTSGTNSEASNASETESDHRDELSDWSLAPTEEERESFLRRGDGRRRGGGGRG
QGGRGRGGGFKGNDDHSRTDNRPRNPREAKGRTTDGSLQIRVDCNNERSVHTKTLQNTSS
EGSRLRTGKDRNQKKEKPDSVDGQQPLVNGVP",FMR1,-,-,632aa(1-632),Q06787,"PhaSePro,DrLLPS,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/Q06787,http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-2426,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0024,http://db.phasep.pro/browse/","[281-422],[443-515],[516-632]","[492-504],[527-549]",In vitro,20 ng/µl [(CGG)99];|9 µM [FMRpolyG],"25 mM NaCl, 10 mM MgCl2","10 mM tris-HCl buffer pH 7.5,12% (w/v) glycerol",23˚C,1 h,drug:PpIX (50µM),FRAP,liquid,We next investigated whether PpIX affects the LLPS of FMRpolyG  in vitro. The phase-separated liquid droplets and hydrogels of com plexes of fluorescein-FMRpolyG and CX rhodamine–CGG99 formed  substantially smaller droplets after PpIX treatment compared to un treated controls,297
27,PMID: 33621982,RNAPS0000471,https://pubmed.ncbi.nlm.nih.gov/33621982,RNA + protein,-,-,(UUUUUACUCCAA)4+UUUUUACUCC,58nt,UUUUUACUCCAAUUUUUACUCCAAUUUUUACUCCAAUUUUUACUCCAAUUUUUACUCC,repeat RNA,-,"sp|P31483|TIA1_HUMAN Nucleolysin TIA-1 isoform p40 OS=Homo sapiens OX=9606 GN=TIA1 PE=1 SV=3
MEDEMPKTLYVGNLSRDVTEALILQLFSQIGPCKNCKMIMDTAGNDPYCFVEFHEHRHAA
AALAAMNGRKIMGKEVKVNWATTPSSQKKDTSSSTVVSTQRSQDHFHVFVGDLSPEITTE
DIKAAFAPFGRISDARVVKDMATGKSKGYGFVSFFNKWDAENAIQQMGGQWLGGRQIRTN
WATRKPPAPKSTYESNTKQLSYDEVVNQSSPSNCTVYCGGVTSGLTEQLMRQTFSPFGQI
MEIRVFPDKGYSFVRFNSHESAAHAIVSVNGTTIEGHVVKCYWGKETLDMINPVQQQNQI
GYPQPYGQWGQWYGNAQQIGQYMPNGWQVPAYGMYGQAWNQQGFNQTQSSAPWMGPNYGV
QPPQGQNGSMLPNQPSGYRVAGYETQ",TIA-1,-,-,386aa(1-386),P31483,"PhaSePro,DrLLPS,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/P31483,http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-0303,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0007,http://db.phasep.pro/browse/",[354-386],"[59-65],[82-104]",In vitro,0.25 µM [RNA];|2.5 µM [TIA-1],50 mM NaCl,"20 mM HEPES
pH 7, 40 mM Arginine",RT,10 min,-,Turbidity measurement,liquid,"To directly test the ability of the oligonucleotide con centration with specific binding sites to modulate TIA-1 condensation, we varied the concentration of TC5 between 0.125 and 5  M and monitored spontaneous phase sepa ration and fibril formation over time of TIA-1 at 2.5  M",58
28,PMID: 32234784,RNAPS0000526,https://pubmed.ncbi.nlm.nih.gov/32234784,RNA + protein,-,-,(UG)12,24nt,UGUGUGUGUGUGUGUGUGUGUGUG,repeat RNA,-,"sp|Q14011|CIRBP_HUMAN Cold-inducible RNA-binding protein OS=Homo sapiens OX=9606 GN=CIRBP PE=1 SV=1|residue=RGG 90-137
RGYRGGSAGGRGFFRGGRGRGRGFSRGGGDRGYGGNRFESRSGGYGG",CIRBP,RGG,-,47aa(90-137),Q14011,"DrLLPS,PhaSepDB","http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-0652,http://db.phasep.pro/browse/",[90-137],"[90-125],[130-137]",In vitro,30 µM [CIRBP];|10 µM (UG)12 RNA,75 mM NaCl,"20 mM Na2HPO4/NaH2PO4 pH 7.5,1 mM DTT,2.5% glycerol",25℃,≤ 30 min,-,Differential interference contrast microscopy,liquid,DIC microscopy showed that CIRBPRGG formed liquid-like condensates in the presence of RNA similar to the full-length protein.,24
29,PMID: 32234784,RNAPS0000526,https://pubmed.ncbi.nlm.nih.gov/32234784,RNA + protein,-,-,(UG)12,24nt,UGUGUGUGUGUGUGUGUGUGUGUG,repeat RNA,-,"sp|Q14011|CIRBP_HUMAN Cold-inducible RNA-binding protein OS=Homo sapiens OX=9606 GN=CIRBP PE=1 SV=1|residue=RSY 137-172
RSGGYGGSRDYYSSRSQSGGYSDRSSGGSYRDSYDSYATHNE",CIRBP,RSY,-,46aa(137-172),Q14011,"DrLLPS,PhaSepDB","http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-0652,http://db.phasep.pro/browse/",[137-172],[137-167],In vitro,30 µM [CIRBP];|10 µM (UG)12 RNA,75 mM NaCl,"20 mM Na2HPO4/NaH2PO4 pH 7.5,1 mM DTT,2.5% glycerol",25℃,≤ 30 min,-,Differential interference contrast microscopy,liquid,DIC microscopy showed that CIRBPRGG formed liquid-like condensates in the presence of RNA similar to the full-length protein.,24
30,PMID: 32234784,RNAPS0000526,https://pubmed.ncbi.nlm.nih.gov/32234784,RNA + protein,-,-,(UG)12,24nt,UGUGUGUGUGUGUGUGUGUGUGUG,repeat RNA,-,"sp|Q14011|CIRBP_HUMAN Cold-inducible RNA-binding protein OS=Homo sapiens OX=9606 GN=CIRBP PE=1 SV=1|residue=RRM 1-67
MASDEGKLFVGGLSFDTNEQSLEQVFSKYGQISEVVVVKDRETQRSRGFGFVTFENIDDA
KDAMMAM",CIRBP,RRM,-,67aa(1-67),Q14011,"DrLLPS,PhaSepDB","http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-0652,http://db.phasep.pro/browse/",-,-,In vitro,30 µM [CIRBP];|10 µM (UG)12 RNA,75 mM NaCl,"20 mM Na2HPO4/NaH2PO4 pH 7.5,1 mM DTT,2.5% glycerol",25℃,≤ 30 min,-,Differential interference contrast microscopy,liquid,DIC microscopy showed that CIRBPRGG formed liquid-like condensates in the presence of RNA similar to the full-length protein.,24
31,PMID: 33991007,RNAPS0000526,https://pubmed.ncbi.nlm.nih.gov/33991007,RNA + protein,-,-,(UG)12,24nt,UGUGUGUGUGUGUGUGUGUGUGUG,repeat RNA,-,"sp|Q14011|CIRBP_HUMAN Cold-inducible RNA-binding protein OS=Homo sapiens OX=9606 GN=CIRBP PE=1 SV=1
MASDEGKLFVGGLSFDTNEQSLEQVFSKYGQISEVVVVKDRETQRSRGFGFVTFENIDDA
KDAMMAMNGKSVDGRQIRVDQAGKSSDNRSRGYRGGSAGGRGFFRGGRGRGRGFSRGGGD
RGYGGNRFESRSGGYGGSRDYYSSRSQSGGYSDRSSGGSYRDSYDSYATHNE",CIRBP,-,-,172aa(1-172),Q14011,"DrLLPS,PhaSepDB","http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-0652,http://db.phasep.pro/browse/",[86-172],"[89-125],[130-167]",In vitro,17µM[CIRBP];|1-30µM[(UG)12],150 mM NaCl,"50 mM NaH2PO4/Na2HPO4,pH 6.5",-,-,-,Turbidity measurement,liquid,"titration of (UG)12RNA to a sample with a fixed CIRBP concentration (17 μM) led to a progressive turbidity increase at low RNA concentrations, whereas higher amounts of RNA had a suppressive effect on CIRBP LLPS",24
32,PMID: 33991007,RNAPS0000526,https://pubmed.ncbi.nlm.nih.gov/33991007,RNA + protein,-,-,(UG)12,24nt,UGUGUGUGUGUGUGUGUGUGUGUG,repeat RNA,-,"sp|Q14011|CIRBP_HUMAN Cold-inducible RNA-binding protein OS=Homo sapiens OX=9606 GN=CIRBP PE=1 SV=1
MASDEGKLFVGGLSFDTNEQSLEQVFSKYGQISEVVVVKDRETQRSRGFGFVTFENIDDA
KDAMMAMNGKSVDGRQIRVDQAGKSSDNRSRGYRGGSAGGRGFFRGGRGRGRGFSRGGGD
RGYGGNRFESRSGGYGGSRDYYSSRSQSGGYSDRSSGGSYRDSYDSYATHNE",CIRBP,-,-,172aa(1-172),Q14011,"DrLLPS,PhaSepDB","http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-0652,http://db.phasep.pro/browse/",[86-172],"[89-125],[130-167]",In vitro,17µM[CIRBP];|7.5µM[(UG)12],150 mM NaCl,"50 mM NaH2PO4/Na2HPO4,pH 6.5",-,-,other_moleculer:0-10mM[ATP],Turbidity measurement,liquid,"Addition of increasing amounts of ATP to RNA-bound and phase separated CIRBP led to a concentration-dependent decrease in turbidity, demonstrating that ATP inhibits CIRBP LLPS ",24
33,PMID: 33991007,RNAPS0000526,https://pubmed.ncbi.nlm.nih.gov/33991007,RNA + protein,-,-,(UG)12,24nt,UGUGUGUGUGUGUGUGUGUGUGUG,repeat RNA,-,"sp|Q14011|CIRBP_HUMAN Cold-inducible RNA-binding protein OS=Homo sapiens OX=9606 GN=CIRBP PE=1 SV=1
MASDEGKLFVGGLSFDTNEQSLEQVFSKYGQISEVVVVKDRETQRSRGFGFVTFENIDDA
KDAMMAMNGKSVDGRQIRVDQAGKSSDNRSRGYRGGSAGGRGFFRGGRGRGRGFSRGGGD
RGYGGNRFESRSGGYGGSRDYYSSRSQSGGYSDRSSGGSYRDSYDSYATHNE",CIRBP,-,-,172aa(1-172),Q14011,"DrLLPS,PhaSepDB","http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-0652,http://db.phasep.pro/browse/",[86-172],"[89-125],[130-167]",In vitro,17µM[CIRBP];|7.5µM[(UG)12],150 mM NaCl,"50 mM NaH2PO4/Na2HPO4,pH 6.5",-,5-30 min,other_moleculer:5mM[ATP],Differential interference contrast microscopy,-,"In order to further validate these findings, we monitored CIRBP phase separation by DIC microscopy. In the presence of substoichiometric amounts of RNA, CIRBP immediately formed small condensates that increased in size over time, most likely due to fusion of condensates, and indicating their “liquid-like” behavior ",24
34,PMID: 33991007,RNAPS0000526,https://pubmed.ncbi.nlm.nih.gov/33991007,RNA + protein,-,-,(UG)12,24nt,UGUGUGUGUGUGUGUGUGUGUGUG,repeat RNA,-,"sp|Q14011|CIRBP_HUMAN Cold-inducible RNA-binding protein OS=Homo sapiens OX=9606 GN=CIRBP PE=1 SV=1
MASDEGKLFVGGLSFDTNEQSLEQVFSKYGQISEVVVVKDRETQRSRGFGFVTFENIDDA
KDAMMAMNGKSVDGRQIRVDQAGKSSDNRSRGYRGGSAGGRGFFRGGRGRGRGFSRGGGD
RGYGGNRFESRSGGYGGSRDYYSSRSQSGGYSDRSSGGSYRDSYDSYATHNE",CIRBP,-,-,172aa(1-172),Q14011,"DrLLPS,PhaSepDB","http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-0652,http://db.phasep.pro/browse/",[86-172],"[89-125],[130-167]",In vitro,17µM[CIRBP];|7.5µM[(UG)12],150 mM NaCl,"50 mM NaH2PO4/Na2HPO4,pH 6.5",-,5-30 min,-,Differential interference contrast microscopy,liquid,"In order to further validate these findings, we monitored CIRBP phase separation by DIC microscopy. In the presence of substoichiometric amounts of RNA, CIRBP immediately formed small condensates that increased in size over time, most likely due to fusion of condensates, and indicating their “liquid-like” behavior ",24
